CLINICAL_TRIALS
trial_result
· 2022-05-17
Clinical Trial Update: Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1 [Phase 2]
Summary
Phase 2 trial of targeted pharmacological and behavioral treatments for tobacco dependence in schizophrenia has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Brown University | Conditions: Tobacco Dependence | Phase 2 | Status: TERMINATED | Results posted: 2022-05-17